US › Healthcare

U.S. Physical Therapy, Inc. (USPH)

US · Healthcare · Medical Care Facilities

$75.86-2.51%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$198.3M
Revenue YoY
+30.0%
Net profit
$-4.3M
Profit YoY
-143.8%
EPS
$0.46
EPS estimate
$0.52
Net margin
-2.2%

EPS came in at 0.46 against a street estimate of 0.52 — a miss of 11.5%.

Key statistics

Market cap
$1.20B
P/E
158.1
Forward P/E
28.7
P/B
2.57
Book value
$30.79
EPS (TTM)
$0.50
Dividend yield
2.26%
52-week high
$91.69
52-week low
$57.76
50-day MA
$68.51
200-day MA
$76.19
Beta
1.14

Analyst view

Analysts rate U.S. Physical Therapy, Inc. a buy (6 buy, 1 hold, 0 sell out of 7) with an average price target of $93.67.

Shareholding

Insiders
2.46%
Institutions
107.65%

Largest institutional holders

FundStake
BlackRock Inc14.51%
Vanguard Group Inc7.13%
Kayne Anderson Rudnick Investment Management LLC7.00%
Morgan Stanley - Brokerage Accounts6.59%
Bahl & Gaynor Inc.5.55%
Copeland Capital Management, LLC5.50%
Vanguard Capital Management, LLC4.36%
State Street Corp4.26%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for U.S. Physical Therapy, Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.